Relationships Between Kohne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal CancerCLINICAL COLORECTAL CANCERIF3.22021-12-013OAAI
Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology databaseFUTURE ONCOLOGYIF2.62021-01-196OA
Impact of biomarkers and primary tumor location on the metastatic colorectal cancer first-line treatment landscape in five European countriesFUTURE ONCOLOGYIF2.62021-01-193OA
Early tumour shrinkage, depth of response and survival outcomes for RAS wild-type metastatic colorectal cancer patients classified by baseline tumour load: Retrospective pooled analysis of panitumumab PRIME/PEAK studiesANNALS OF ONCOLOGYIF65.42020-07-010OAAI
Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients' Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology CentersCLINICAL COLORECTAL CANCERIF3.22020-06-0110PREAI
Relationship Between Tumor Response and Tumor-Related Symptoms in RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses From 3 Panitumumab TrialsCLINICAL COLORECTAL CANCERIF3.22019-12-013OAAI
The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal CancerDRUGSIF14.42019-07-2547OAAI
Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trialsBRITISH JOURNAL OF CANCERIF6.82018-07-1735OAAI